Moneycontrol PRO
Upcoming Webinar:Innovate Your Future at India Inc. on the Move on August 26 and 27, 2021 at 10am, with Rockwell Automation
you are here: HomeNewsIndia

Dr Reddy's completes the acquisition of Wockhardt's select business divisions

The business comprises a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines, which would transfer to Dr Reddys along with related sales and marketing teams and a manufacturing plant located in Baddi, Himachal Pradesh with all plant employees, a press release from the drug maker said.

June 10, 2020 / 04:36 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Dr Reddy's Laboratories Ltd on June 10 announced that it has completed the acquisition of select divisions of Wockhardt Ltd's branded generics business in India and from a few other international territories of Nepal, Sri Lanka, Bhutan and Maldives.

The business comprises a portfolio of 62 brands in multiple therapy areas such as Respiratory, Neurology, VMS, Dermatology, Gastroenterology, Pain and Vaccines, which would transfer to Dr Reddys along with related sales and marketing teams and a manufacturing plant located in Baddi, Himachal Pradesh with all plant employees, a press release from the drug maker said.

On February 12, 2020, Dr Reddys signed a Business Transfer Agreement(BTA) with Wockhardt to acquire the above- referred business undertaking for an upfront consideration of Rs 1,850 crore.

In view of the COVID-19 pandemic and the consequent government restrictions, there has been a reduction in the revenue from the sales of the products forming part of the Business Undertaking during March and April 2020, it said.

Subsequently, through an amendment to the BTA, Dr Reddys and Wockhardt that 1,483 crore would be paid on the date of closing the deal consideration, and the rest would be through different ways,the release said.

Close

G V Prasad, Co-Chairman and Managing Director of Dr Reddys said this deal is in line with the companys strategic focus on India and has paved a path for accelerated growth and leadership in the domestic market.

"We believe that the acquired portfolio offers a good growth potential for us. We welcome the employees joining us from Wockhardt to the family of Dr Reddys," Prasad said.
PTI
first published: Jun 10, 2020 04:25 pm

stay updated

Get Daily News on your Browser
Sections
ISO 27001 - BSI Assurance Mark